Purchase Order 75N94023P00207
Award Date 2/17/23
Potential Completion Date 2/16/24
Potential Value $45K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $15,400 firm fixed price purchase order to Pine Pharmaceuticals LLC. The contract is for the delivery of 6,6 D2Glucose intravenous stable isotopes to support metabolic research studies being conducted by NIDDK in Tonawanda, New York. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility specializing in high-quality pharmaceutical compounds and repackaged products, with...
- This is a $81,714.96 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of intravenous stable isotope glucose (D5 glycerol) to support metabolic research. The contract has an ultimate completion date of April 30,...
- This is a $27,384.76 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of 3 batches/shipments of 60 units each of the intravenous stable isotope D5 glycerol, which is required for metabolic research studies conducted...
- The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $237,922.80 firm fixed price purchase order to Pine Pharmaceuticals LLC. The purpose of this acquisition is to procure an intravenous stable isotope to support metabolic research studies being conducted by the funding agency. The solicitation sought a stable isotope that meets NIH specifications for use in clinical human research, referencing a history of safe use in such studies. No...
- This is a $15,000 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the provision of non-severable task order 1 for metabolic isotopes to support research studies conducted by various HHS agencies. Pine Pharmaceuticals is an FDA-registered 503B...
- This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope (6,6 D2-Glucose) for metabolic research. The $138,712.14 contract has an ultimate completion date of November 2, 2024 and was awarded on a sole-source basis without a small business set-aside. Pine Pharmaceuticals is an...
- This is a firm-fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the procurement of 6,6 D2-glucose 72.9 mg/ml (30 ml) vials, which are likely being used to support metabolic research studies conducted by NICHD. The contract has a ceiling value of $12,371.12 and a period of...
- This $116,700.00 firm fixed price purchase order was awarded to Pine Pharmaceuticals LLC, a for-profit limited liability company, by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations. The contract has a completion date of August 17, 2023 and does not have a set-aside designation. Based on the information provided, Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that has previously provided pharmaceutical...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company in Tonawanda, New York. The contract, valued at $119,062.95, is for the production of drug capsules. The award does not have a set-aside designation. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in pharmaceutical compounding,...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $51,625 purchase order to Sigma-Aldrich, Inc. of St. Louis, Missouri. Under the terms of the contract, Sigma-Aldrich will provide glucose isotopes to NIDDK in support of its biomedical research efforts. Performance will take place in St. Louis over a two-month period concluding in late September...